Ajitha prodrug has established a simple, yet powerful chemistry platform enabling best-in-class payload diversities in Tubulysins, Auristatins, and various other therapeutic payloads. Ajitha Prodrug is specialized in development of optimized linkers, and suitable conjugation strategies to meet wide ranging needs of research clients. We also pioneer in the small molecule and peptide drug conjugations for targeted delivery studies.
Ajitha Prodrug
Committed To Affordable Oncology Solutions
And Effective Human Care
.png)
Our Core Values
Vision
We want to be a “Responsible, Disruptive and Leading” producer of “Novel Tubulysin Derivatives and Adjacencies” in the fast-growing Antibody Drug Conjugates (ADC) segmentFocus
Enabling Oncological treatment to be “Affordable while upholding the core Medical Ethical Pillars”Strategy
- Innovative MCR (Multi Component Reaction) chemistry techniques reduce R&D efforts significantly
- Smart formulations for unmet medical demands
- Stakeholder centric collaborative approach
- Reliable and agile supply chain process